Hyundai Motor Group is considering deploying the four-legged, dog-like robot developed by Boston Dynamics Inc. dubbed Spot as a facility safety inspector and security guard in its production lines.
This was revealed by Boston Dynamics CEO Robert Playter.
Hyundai is also seeking to use Boston Dynamics' box-handling robot Stretch, which will be commercially available from next year.
Hyundai Motor has an 80 percent stake in Boston Dynamics, which it acquired from Japan’s SoftBank Group for $880 million in December.
The company's chairman Chung Euisun purchased the remaining 20 percent stake with his own $206 million.
Since the Boston Dynamics acquisition, Hyundai has increasingly been seeking to deploy robots in smart factories and last-mile product delivery, while utilizing the US firm's technology to its urban air mobility (UAM) and autonomous driving and projects.
Meanwhile, Boston Dynamics is using Hyundai Motor's technologies to cut its production costs and upgrade quality.
Playter noted that Boston Dynamics would soon reach a breakeven point and become profitable next year, for the first time in its 30-year history, with its newest robot Stretch becoming commercially available.
It is also seeking to lower its robot prices and may offer robot rental services. Spot costs $74,500.


Asian Stocks Slip as Tech Rout Deepens, Japan Steadies Ahead of Election
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
South Africa Eyes ECB Repo Lines as Inflation Eases and Rate Cuts Loom
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Dollar Near Two-Week High as Stock Rout, AI Concerns and Global Events Drive Market Volatility
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Vietnam’s Trade Surplus With US Jumps as Exports Surge and China Imports Hit Record
Asian Markets Surge as Japan Election, Fed Rate Cut Bets, and Tech Rally Lift Global Sentiment
Nikkei 225 Hits Record High Above 56,000 After Japan Election Boosts Market Confidence
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Australian Household Spending Dips in December as RBA Tightens Policy 



